Reference health

S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure

https://doi.org/10.1161/hypertensionaha.117.09088
CiteStamped reference-health badge
2 of 42 checkable references need attention · checked 2026-07-23

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

does not resolve to a known work10.1172/JCI18004
does not resolve to a known work10.1172/JCI14172
The 40 checked references that resolve
resolves10.1172/JCI10905
Edg-1, the G protein–coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
resolves10.1074/jbc.M403937200
The Sphingosine-1-phosphate Receptors S1P1, S1P2, and S1P3 Function Coordinately during Embryonic Angiogenesis
resolves10.1006/bbrc.1999.1586
Sphingosine 1-Phosphate Induces Angiogenesis: Its Angiogenic Action and Signaling Mechanism in Human Umbilical Vein Endothelial Cells
resolves10.1016/S0092-8674(00)81661-X
Vascular Endothelial Cell Adherens Junction Assembly and Morphogenesis Induced by Sphingosine-1-Phosphate
resolves10.1152/ajpheart.01089.2002
Sphingosine 1-phosphate and control of vascular tone
resolves10.1038/nm.3934
Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure
resolves10.1074/jbc.M008375200
Sphingosine 1-Phosphate and Activation of Endothelial Nitric-oxide Synthase
resolves10.1172/jci.insight.85484
Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload
resolves10.1016/S0014-2999(03)01731-X
S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate
resolves10.1038/sj.bjp.0707581
Analysis of sphingosine 1‐phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools
resolves10.1124/jpet.116.233205
S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis
resolves10.1074/jbc.M700370200
Deafness and Stria Vascularis Defects in S1P2 Receptor-null Mice
resolves10.1124/jpet.103.062828
Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes
resolves10.1074/jbc.C200176200
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
resolves10.1016/j.ahj.2014.06.028
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications
resolves10.1056/NEJMoa052643
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
resolves10.1038/nature02284
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
resolves10.1126/science.1070238
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
resolves10.1177/1352458509357065
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
resolves10.1182/blood-2003-02-0460
G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation
resolves10.1016/j.devcel.2012.07.015
Flow-Regulated Endothelial S1P Receptor-1 Signaling Sustains Vascular Development
resolves10.1111/j.1476-5381.2009.00451.x
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
resolves10.1074/jbc.M610318200
Immunosuppressive and Anti-angiogenic Sphingosine 1-Phosphate Receptor-1 Agonists Induce Ubiquitinylation and Proteasomal Degradation of the Receptor
resolves10.1016/S1474-4422(14)70049-3
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
resolves10.1371/journal.pone.0052985
The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P1) and Hypertension (S1P3) in Rat
resolves10.1111/j.1476-5381.2012.01865.x
FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinase
resolves10.1161/CIRCRESAHA.107.165845
Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate
resolves10.1152/physrev.1995.75.3.519
Flow-mediated endothelial mechanotransduction
resolves10.1007/s00424-005-1424-4
The mechanosensitive nature of TRPV channels
resolves10.1038/nm1338
Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice
resolves10.1242/jcs.02541
Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells
resolves10.1038/nature03952
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
resolves10.1161/CIRCRESAHA.108.192765
Ciliary Polycystin-2 Is a Mechanosensitive Calcium Channel Involved in Nitric Oxide Signaling Cascades
resolves10.1146/annurev.bioeng.9.060906.151959
The Structure and Function of the Endothelial Glycocalyx Layer
resolves10.1172/JCI81067
P2Y2 and Gq/G11 control blood pressure by mediating endothelial mechanotransduction
resolves10.1114/1.1397792
Modulation of ATP/ADP Concentration at the Endothelial Surface by Shear Stress: Effect of Flow-Induced ATP Release
resolves10.1172/JCI40659
Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice
resolves10.1161/CIRCRESAHA.110.226464
Sphingosine-1-Phosphate–Dependent Activation of p38 MAPK Maintains Elevated Peripheral Resistance in Heart Failure Through Increased Myogenic Vasoconstriction
resolves10.1161/01.CIR.0000080324.12530.0D
Sphingosine Kinase Modulates Microvascular Tone and Myogenic Responses Through Activation of RhoA/Rho Kinase
resolves10.1161/CIRCRESAHA.108.173575
Role of Sphingosine-1-Phosphate Phosphohydrolase 1 in the Regulation of Resistance Artery Tone
The 2 references without a DOI — listed, not checked
no DOI — not checkedWorld Health Organization. Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization; 2011.
no DOI — not checkedRubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 1986;250(6 pt 2):H1145–H1149.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1161/hypertensionaha.117.09088"><img src="https://citestamp.com/citestamped/10.1161/hypertensionaha.117.09088/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1161/hypertensionaha.117.09088/badge.svg)](https://citestamp.com/citestamped/10.1161/hypertensionaha.117.09088)